A powerful study published in the journal Anticancer Research titled, “Natural Products That Target Cancer Stem Cells,” has made our job much easier of identifying this special category of cancer killers by reviewing the extant literature on the topic and listing the top 25 substances in this category. They are listed here below, along with some of their commonly recognizable dietary sources:
Epigallocatechin-3-gallate (EGCG) - Green Tea
6-Gingerol - Ginger
β-Carotene - Carrot, Leafy Greens
Baicalein - Chinese Skullcap
Curcumin - Turmeric
Delphinidin - Blueberry, raspberrry
Flavonoids (Genistein) - Soy, red clover, coffee
Guggulsterone - Commiphora (myrrh tree)
Isothiocyanates - Cruciferous vegetables
Linalool - Mint
Lycopene - Grapefruit, tomato
Parthenolide - Feverfew
Perylill alcohol - Mint, cherry, lavender
Piperine - Black pepper
Platycodon saponin - Platycodon grandiflorum
Psoralidin - Psoralea corylilyfolia
Quercetin - Capers, onion
Resveratrol - Grapes, plums, berries
Salinomycin - Streptomyces albus
Silibinin - Milk Thistle
Ursolic acid - Thyme, basil, oregano
Vitamin D3 - Fish, egg yolk, beef, cod liver oil
Withaferin A - Withania somnifera (ashwaganda)
Why Are These Substances so Important?
The primary reason why conventional chemotherapy and radiotherapy have failed to produce any significant improvements in cancer survival rates is because cancer stem cells are resistant to these interventions. In fact, chemotherapy and especially radiation are both capable of increasing the number and virulence of these cells in a tumor, while at the same time having the well known side effect of further damaging the patient’s immune system.
While the cancer industry is still very much resistant to incorporating the implications of these findings into their standard of care (which is highly unethical), there are an increasing number of health practitioners that will not turn their back on the truth and are very much interested in alternative ways to prevent and treat cancer using food and/or plant-based approaches.
The new study addresses the relevance of cancer stem cells as follows:
At present, the cancer industry has failed to produce a single drug that targets the cancer stem cell population of cells within a tumor, as confirmed by the study:
The ability to selectively target cancer cells, and cancer stem cells in particular, while leaving intact the non-tumor cells in tissue is extremely important. We have created a section on our database that indexes research on these substances and now includes sixty seven of them here.
Republished from GreenMedInfo.com










